CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)
Not Applicable
Not yet recruiting
- Conditions
- Atherosclerotic Disease
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 240
- Registration Number
- NCT06910111
- Locations
- 🇮🇹
Pisa University Hospital - Clinical Research Unit, Pisa, Tuscany, Italy
🇮🇹University Gabriele d'Annunzio Chieti - Pescara, Chieti, Italy
🇮🇹S. Maria della Misericordia Hospital, Perugia, Italy
Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption
Not Applicable
Completed
- Conditions
- Cholesterol Lowering
- Interventions
- Device: Polyglucosamine L112
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT05038436
- Locations
- 🇩🇪
Phase I-Unit, Study Center Bonn (SZB), University Hospital Bonn, Bonn, North-Rhine Westfalia, Germany
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
Phase 4
Completed
- Conditions
- Weight Loss
- Interventions
- Drug: Polyglucosamine L112Other: Placebo
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 150
- Registration Number
- NCT04375696
- Locations
- 🇮🇹
Azienda di Servizi alla Persona Istituzioni Assistenziali Riunite di Pavia, Pavia, Lombardia, Italy
The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II
Not Applicable
Completed
- Conditions
- Xerostomia Due to Hyposecretion of Salivary GlandDiabetes Mellitus, Type 2
- Interventions
- Device: artificial saliva spray (AS)Other: maritime throat spray (TT)
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 21
- Registration Number
- NCT03452085
- Locations
- 🇮🇹
Irwin Labs, University of Chieti, Chieti, PE, Italy
Efficacy of Polyglucosamine Long Term Treatment
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Other: placeboDevice: polygucosamine
- First Posted Date
- 2016-02-15
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 100
- Registration Number
- NCT02682277
- Locations
- 🇮🇹
MAP Center, Rende, Cosenza, Italy
RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
Not Applicable
Completed
- Conditions
- OverweightObesity
- Interventions
- Device: polyglucosamine
- First Posted Date
- 2015-08-20
- Last Posted Date
- 2015-08-20
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 64
- Registration Number
- NCT02529631
- Locations
- 🇮🇹
MAP Center, Rende, Cosenza, Italy
🇩🇪Diabetological Center, Dreieich, Hesse, Germany
Efficacy of Polyglucosamine for Weight Loss
Not Applicable
Completed
- Conditions
- Overweight and Obesity
- Interventions
- Other: PlaceboDevice: Polyglucosamine
- First Posted Date
- 2015-04-08
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Certmedica International GmbH
- Target Recruit Count
- 115
- Registration Number
- NCT02410785
- Locations
- 🇩🇪
Salztal Klinik GmbH, Bad Soden-Salmünster, Hessia, Germany
🇮🇹MAP Center, Rende, Cosenza, Italy
© Copyright 2025. All Rights Reserved by MedPath